January 8, 2018
In this video, R. Charles Coombes, MD, PhD, of Imperial College London, United Kingdom, discusses results of REACT (Randomised European Celecoxib Trial), a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.
Coombes presented results of this study (abstract GS3-03) at the 2017 San Antonio Breast Cancer Symposium (SABCS).
